Stock BPLPHARMA6 BHARAT PARENTERALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Bharat Parenterals Limited

Equities

BPLPHARMA6

INE365Y01019

Pharmaceuticals

Delayed Bombay S.E.
Other stock markets
 00:49:22 2024-06-26 EDT 		5-day change 1st Jan Change
1,489 INR -1.54% Intraday chart for Bharat Parenterals Limited +6.34% +83.86%
06-24 Bharat Parenterals Limited agreed to acquire an unknown majority stake in Varenyam Biolifesciences Private Limited for INR 22.56 million. CI
06-06 Bharat Parenterals to Raise Stake in Subsidiary Innoxel Lifesciences MT

Valuation

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024
Capitalization 1 1,261 812.5 1,920 1,971 1,940 6,531
Enterprise Value (EV) 1 1,183 724.2 1,598 1,800 2,359 7,998
P/E ratio 5.93 x 3.37 x 9.42 x 9.31 x 7.97 x 45 x
Yield - - - - 0.22% 0.09%
Capitalization / Revenue 0.56 x 0.35 x 0.93 x 0.93 x 0.88 x 2.52 x
EV / Revenue 0.53 x 0.31 x 0.77 x 0.85 x 1.08 x 3.08 x
EV / EBITDA 3.33 x 2.19 x 5.73 x 6.3 x 8.67 x 30.1 x
EV / FCF 46.9 x 220 x 24 x -6.55 x -24.6 x -5.93 x
FCF Yield 2.13% 0.46% 4.16% -15.3% -4.06% -16.9%
Price to Book 1.34 x 0.69 x 1.33 x 1.19 x 1.06 x 3.31 x
Nbr of stocks (in thousands) 5,730 5,730 5,730 5,775 5,775 5,820
Reference price 2 220.0 141.8 335.1 341.4 336.0 1,122
Announcement Date 9/5/19 9/5/20 9/6/21 9/2/22 9/5/23 6/12/24
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Marzo 2019 2020 2021 2022 2023 2024
Net sales 1 2,249 2,328 2,072 2,123 2,193 2,594
EBITDA 1 355.6 330.2 278.9 285.6 272 265.7
EBIT 1 294.3 271.4 218.6 219 213.6 175.5
Operating Margin 13.09% 11.66% 10.55% 10.32% 9.74% 6.77%
Earnings before Tax (EBT) 1 345.9 328 271.2 278.8 321.7 187.2
Net income 1 212.5 241.4 203.9 210.5 243.4 145.2
Net margin 9.45% 10.37% 9.84% 9.92% 11.1% 5.6%
EPS 2 37.08 42.14 35.59 36.67 42.14 24.94
Free Cash Flow 1 25.25 3.297 66.49 -274.6 -95.83 -1,349
FCF margin 1.12% 0.14% 3.21% -12.93% -4.37% -51.99%
FCF Conversion (EBITDA) 7.1% 1% 23.84% - - -
FCF Conversion (Net income) 11.88% 1.37% 32.61% - - -
Dividend per Share - - - - 0.7500 1.000
Announcement Date 9/5/19 9/5/20 9/6/21 9/2/22 9/5/23 6/12/24
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt 1 - - - - 419 1,467
Net Cash position 1 77.1 88.3 322 172 - -
Leverage (Debt/EBITDA) - - - - 1.539 x 5.52 x
Free Cash Flow 1 25.2 3.3 66.5 -275 -95.8 -1,349
ROE (net income / shareholders' equity) 25.5% 22.8% 15.5% 13.3% 12.5% 4.61%
ROA (Net income/ Total Assets) 12.6% 9.79% 7.08% 6.45% 4.63% 2.57%
Assets 1 1,681 2,466 2,882 3,266 5,255 5,651
Book Value Per Share 2 164.0 206.0 251.0 287.0 317.0 339.0
Cash Flow per Share 2 19.30 17.60 2.930 5.890 13.60 15.00
Capex 1 88.8 150 58.6 390 50.7 1,043
Capex / Sales 3.95% 6.45% 2.83% 18.34% 2.31% 40.21%
Announcement Date 9/5/19 9/5/20 9/6/21 9/2/22 9/5/23 6/12/24
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
BHARAT PARENTERALS LIMITED Stock Bharat Parenterals Limited
+83.86% 118M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.19% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+47.26% 654B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.09% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+21.92% 337B
ASTRAZENECA PLC Stock AstraZeneca PLC
+18.40% 247B
ROCHE HOLDING AG Stock Roche Holding AG
+3.64% 229B
NOVARTIS AG Stock Novartis AG
+12.98% 219B
AMGEN INC. Stock Amgen Inc.
+10.86% 171B
PFIZER, INC. Stock Pfizer, Inc.
-2.78% 159B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. BPLPHARMA6 Stock
  4. Financials Bharat Parenterals Limited